PELLEGRINI-GIAMPIETRO, DOMENICO EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 10.986
EU - Europa 7.747
AS - Asia 4.786
SA - Sud America 523
AF - Africa 151
OC - Oceania 92
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.291
Nazione #
US - Stati Uniti d'America 10.887
PL - Polonia 2.236
RU - Federazione Russa 2.195
SG - Singapore 1.371
CN - Cina 1.140
IT - Italia 972
HK - Hong Kong 794
IE - Irlanda 570
VN - Vietnam 480
SE - Svezia 479
BR - Brasile 404
KR - Corea 393
DE - Germania 245
FI - Finlandia 229
FR - Francia 224
UA - Ucraina 191
GB - Regno Unito 153
IN - India 153
TR - Turchia 94
AU - Australia 91
CH - Svizzera 90
NL - Olanda 67
JO - Giordania 66
JP - Giappone 58
ID - Indonesia 52
BD - Bangladesh 50
CA - Canada 49
CI - Costa d'Avorio 40
AR - Argentina 37
MX - Messico 35
ES - Italia 27
IQ - Iraq 26
PK - Pakistan 23
ZA - Sudafrica 22
BE - Belgio 20
EC - Ecuador 20
NG - Nigeria 18
PY - Paraguay 15
PH - Filippine 14
CL - Cile 13
CO - Colombia 13
EG - Egitto 12
MA - Marocco 11
SA - Arabia Saudita 10
MY - Malesia 9
VE - Venezuela 9
DZ - Algeria 8
UZ - Uzbekistan 8
AT - Austria 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BJ - Benin 6
LT - Lituania 6
NP - Nepal 6
SC - Seychelles 6
BG - Bulgaria 5
PE - Perù 5
BY - Bielorussia 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EU - Europa 4
KE - Kenya 4
LB - Libano 4
MU - Mauritius 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CM - Camerun 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
JM - Giamaica 3
KZ - Kazakistan 3
PT - Portogallo 3
RO - Romania 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
DK - Danimarca 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
MM - Myanmar 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
GF - Guiana Francese 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
Totale 24.280
Città #
Warsaw 2.233
Santa Clara 2.030
Ashburn 1.167
Singapore 974
Fairfield 958
Hong Kong 670
Chandler 585
Dublin 567
Woodbridge 448
Seattle 420
Seoul 384
Cambridge 377
Houston 355
Wilmington 331
San Jose 308
Beijing 273
Jacksonville 247
Buffalo 238
Ann Arbor 217
Hefei 204
Los Angeles 202
The Dalles 196
Florence 169
Council Bluffs 153
Lawrence 146
Altamura 145
Princeton 138
Lauterbourg 130
Ho Chi Minh City 127
Dallas 113
Hanoi 113
Boston 105
Boardman 96
Melbourne 90
Moscow 85
Bern 79
Shanghai 76
Helsinki 70
Mumbai 69
Milan 66
San Diego 66
New York 63
Brunswick 60
Munich 58
Medford 56
Tokyo 54
Dong Ket 48
São Paulo 46
Rome 42
Jakarta 41
Abidjan 40
Dearborn 39
Paris 39
Turku 36
Izmir 35
Kent 35
Norwalk 35
Redondo Beach 29
Orem 28
Falls Church 27
London 27
Frankfurt am Main 25
Phoenix 24
Chennai 21
Guangzhou 21
Brussels 20
Clifton 20
Da Nang 19
Toronto 19
Turin 18
Washington 18
Atlanta 17
Tianjin 17
Yubileyny 17
Johannesburg 16
Lappeenranta 16
Abuja 15
Haiphong 15
Naples 15
Amsterdam 14
Belo Horizonte 14
Chicago 14
Hillsboro 14
Montreal 14
Andover 13
San Francisco 13
Bengaluru 12
Portsmouth 12
Denver 11
Rio de Janeiro 10
West Jordan 10
Baghdad 9
Shenzhen 9
Barcelona 8
Brasília 8
Dhaka 8
Fort Wayne 8
Lahore 8
Manchester 8
Mexico City 8
Totale 16.816
Nome #
Anticonvulsant and Neuroprotective Effects of the Thyroid Hormone Metabolite 3-Iodothyroacetic Acid. 431
Azithromycin: assessment of intrinsic cytotoxic effects on corneal epithelial cell cultures 345
Il Doping e le sostanze dopanti. 337
Neuroprotective effects of topiramate and memantine in combination with hypothermia in hypoxic-ischemic brain injury in vitro and in vivo 328
Activation of the histaminergic H3 receptor induces phosphorylation of the Akt/GSK-3 beta pathway in cultured cortical neurons and protects against neurotoxic insults. 319
Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. 300
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold 293
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 293
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability 293
Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance 289
Interplay between histone acetylation/deacetylation and poly(ADPribosyl)ation in the development of ischemic tolerance in vitro 288
Group I metabotropic glutamate receptors stimulate the activity of poly(ADP-ribose) polymerase in mammalian mGlu1-transfected cells and in cortical cell cultures. 283
N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity 277
Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors 274
The metaplastic effects of NMDA receptors blockade on reactivation of instrumental memories in rats 259
Glutamate receptor and transporter modifications in rat organotypic hippocampal slice cultures exposed to oxygen-glucose deprivation: The contribution of cyclooxygenase-2 257
Glutamate Receptor-Mediated Neurotoxicity in a Model of Ethanol Dependence and Withdrawal in Rat Organotypic Hippocampal Slice Cultures 254
Dexpramipexole improves bioenergetics and outcome in experimental stroke 254
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 240
Topiramate Concentrations In Neonates Treated With Prolonged Whole Body Hypothermia For Hypoxic Ischaemic Encephalopathy 239
A new ophthalmic formulation containing antiseptics and dexpanthenol: In vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells 237
The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models 235
Differential role of poly(ADP-ribose) polymerase-1 in apoptotic and necrotic neuronal death induced by mild or intense NMDA exposure in vitro 233
Niosomal Formulation of a Lipoyl-Carnosine Derivative Targeting TRPA1 Channels in Brain 231
Bicuculline Reverts the Neuroprotective Effects of Meloxicam in an Oxygen and Glucose Deprivation (OGD) Model of Organotypic Hippocampal Slice Cultures 230
Ethanol neurotoxicity is mediated by changes in expression, surface localization and functional properties of glutamate AMPA receptors 226
Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model 217
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: Molecular modeling and pharmacological studies. 213
Antiseptics and the Ocular Surface: In Vitro Antimicrobial Activity and Effects on Conjunctival and Corneal Epithelial Cells of a New Liposomal Ocular Spray Containing Biosecur Citrus Extract 209
AN ACTIVITY-DEPENDENT SPERMINE-MEDIATED MECHANISM THAT MODULATES GLUTAMATE TRANSMISSION 204
Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: In vitro and in vivo evaluation 204
Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to post-ischemic neuronal injury in vitro and in vivo. 202
The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation 200
Long-term neuro-glial co-cultures as a brain aging model: hallmarks of senescence, miRNA expression profiles and comparison with in vivo models 200
Ethanol Toxicity During Brain Development: Alterations of Excitatory Synaptic Transmission in Immature Organotypic Hippocampal Slice Cultures 199
Acute phencyclidine administration reduces extracellular glutamate levels and the expression of synaptophysin and SNAP-25 in rat frontal cortex 194
BRAIN-TARGETED DELIVERY OF ANDROGRAPHOLIDE USING SOLID LIPID NANOPARTICLES: IN VITRO AND IN VIVO EVALUATION 194
Reconsolidation of sucrose instrumental memory in rats: The role of retrieval context 191
Using organotypic hippocampal slice cultures to gain insight into mechanisms responsible for the neuroprotective effects of meloxicam: A role for gamma aminobutyric and endoplasmic reticulum stress 188
The distinct role of mGlu1 receptors in post-ischemic neuronal death 187
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. 186
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca2+-permeable AMPA receptors 184
Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva 182
Evaluation of Conventional and Hyaluronic Acid-Coated Thymoquinone Liposomes in an In Vitro Model of Dry Eye 181
Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model 181
Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage. 180
Biochemical and behavioural studies on indole-pyruvic acid: a keto-analogue of tryptophan. 180
Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury 179
CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices 176
1-Amino-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia 174
Neuroprotective effects of thymoquinone by the modulation of ER stress and apoptotic pathway in in vitro model of excitotoxicity. 174
Differential mechanisms of tolerance induced by NMDA and DHPG preconditioning 172
Virtual screening and in vitro experiments highlight cannabidiol as a drug-like phosphodiesterase 9 inhibitor 169
NAPOR-3 RNA binding protein is required for apoptosis in hippocampus 169
A new endogenous anxiolytic agent: L-pyroglutamic acid. 167
Enhanced Neuroprotective Effects of Panax Ginseng G115® and Ginkgo Biloba GK501® Combinations In Vitro Models of Excitotoxicity 166
Neuroprotective effects of cannabidiol but not Δ9-tetrahydrocannabinol in rat hippocampal slices exposed to oxygen-glucose deprivation: studies with Cannabis extracts and selected cannabinoids. 165
Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance 164
Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. 164
The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine 163
Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K–Akt signaling pathway: A novel postconditioning strategy? 163
The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke. 163
Rat hippocampal slice culture models for the evaluation of neuroprotective agents. 162
Changes in physical activity levels, eating habits and psychological well-being during the Italian COVID-19 pandemic lockdown: Impact of socio-demographic factors on the Florentine academic population 162
Are Ca2+-permeable kainate/AMPA receptors more abundant in immature brain? 162
GAT-1 regulates both tonic and phasic GABAA receptor-mediated inhibition in the cerebral cortex 161
Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model 158
DHPG and NMDA preconditioning induce ischemic tolerance with differential mechanisms 158
Preparation of liposomal formulations for ocular delivery of thymoquinone: in vitro evaluation in HCEC-2 e HConEC cells. 158
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia 157
(+)MCPG induces PKC-epsilon translocation in cortical synaptosomes through a PLD-coupled mGluR 156
Interplay between group I mGlu and the endocannabinoid system in the hippocampus: studies in models of cerebral ischemia 153
Tolerance Induced by (S)-3,5-Dihydroxyphenylglycine Postconditioning is Mediated by the PI3K/Akt/GSK3β Signalling Pathway in an In Vitro Model of Cerebral Ischemia 151
Erythropoietin attenuates post-traumatic injury in organotypic hippocampal slices 149
An electrophysiological study of the mGlu1 receptors ability to modulate endocannabinoids production and inhibitory synaptic transmission in the CA1 hippocampal area 148
Poly (ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia 147
Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol 147
Beneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic–ischaemic encephalopathy 146
In vitro comparison of the cytotoxic effects of clinically available ophthalmic solutions of fluoroquinolones on human keratocytes 146
Nerve growth factor (NGF) mimetics modulate ischemic brain damage 142
(2R, 1’S, 2’R, 3’S)-2-(2’-Carboxy-3’-phenylcyclopropyl)glycine (PCCG-13), the first potent and selective competitive antagonist of PLD-coupled metabotropic receptors. Asymmetric synthesis and preliminary biological reports. 142
The Neuroprotective Effects of mGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission via a Presynaptic CB1 Receptor Mechanism 140
Antidepressant-induced increase in GluA2 expression does not translate in changes of AMPA receptor-mediated synaptic transmission at CA3/CA1 synapses in rats 140
mGlu1 receptors and endocannabinoids: neuroprotection studies in an in vitro model of cerebral ischemia 140
Nerve Growth Factor mimetics with neuroprotective activity in ischemic brain damage 139
Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus 138
Neuroprotective effects of propofol in acute cerebral injury 137
Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. 137
Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy 136
Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol. 136
Transient focal ischemia triggers neuronal expression of GAT-3 in the rat perilesional cortex 136
Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage 133
Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake 132
Preconditioning With NMDA and DHPG Induces Ischemic Tolerance With Differential Mechanisms In An In Vitro Hippocampal Slice Model Of Excitotoxicity 132
Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca(2+) Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities? 131
Antagonist pharmacology of metabotropic glutamate receptors coupled to phospholipase D activation in adult rat hippocampus: focus on (2R,1'S,2'R,3'S)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine versus 2,3-dihydroxyphenylglycine 129
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia. 128
Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity? 127
Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. 127
Neuroprotective effects of propofol in an in vitro model of cerebral ischemia 125
Totale 19.297
Categoria #
all - tutte 66.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021230 0 0 0 0 0 0 0 0 0 0 89 141
2021/2022932 34 83 56 39 36 57 55 79 57 44 144 248
2022/20232.595 228 427 99 187 227 456 338 132 292 19 77 113
2023/2024997 32 127 160 48 85 123 54 202 18 54 59 35
2024/20256.447 251 599 403 970 1.895 750 116 443 364 172 250 234
2025/20266.648 819 963 835 435 792 276 909 405 532 461 221 0
Totale 24.452